Tying it all together for start up success
Alan Nelson is heading the Predictive Health Analytics Initiative that aims to change the paradigm in healthcare from treating late stage disease to early diagnosis and preventive therapies that are cost-effective. He served as the Executive Director of the Biodesign Institute at ASU and holds professorships in Bioengineering and physics. He is the founder and CEO of three companies, the most recent being VisionGate, the innovator of the LuCED lung cancer early detection test. VisionGate was awarded the start-up of the year award at the recent Governors’ celebration of innovation. Alan has a PhD in Biophysics from Berkeley, holds 66 issued patents, and has published over 100 scholarly papers in biomedical imaging.
From Discovery to Development to Delivery: Biodesign
Raymond N. DuBois, MD, PhD , executive director of The Biodesign Institute at Arizona State University explains the history and the value of biodesign and shares a look at the bioinspired, use inspired, research being done by innovative teams at The Biodesign Institute in their three focus areas of health, energy, and security.
Arbsource was founded to transform wastewater treatment from a costly energy liability into a valuable resource through state-of-the-art microbial electrochemical cell technologies. Our team includes domain experts in the water industry passionate about contributing to a safe, secure, and sustainable water infrastructure with our award-winning Arbcell biotechnology.
Update from ASU Biodesign's Dr. Raymond DuBois
Dr. Ray DuBois , M.D., Ph.D. Dr. DuBois is a world-renowned physician-scientist who has devoted his career to understanding the linkages between inflammation and cancer, particularly colon cancer. He assumed his new role as Executive Director of the Biodesign Institute in December of 2012, coming by way of Houston as provost of the prestigious M.D. Anderson Cancer Center.
Jennifer Kehlet Barton, PhD, 2012 Bioscience Educator of the Year
Jennifer Kehlet Barton, Ph.D., Associate Vice President for Research and Professor, Biomedical Engineering at The University of Arizona was named the 2012 Michael A. Cusanovich Bioscience Educator of the Year by the Arizona Bioindustry Association. Dr. Barton was nominated by students, past and present with supporting nominations by her co-workers, and selected for this honor by an independent panel of judges from across the state of Arizona for her contributions to all aspects of bioscience education. They include her skill as a course instructor, her compassion and patience as a mentor and adviser to undergraduate and graduate students, her strategic leadership in creating a learning environment and career path for students via her development and leadership of the UA Biomedical Engineering Programs, her recent role as Assistant Director of the BIO5 Institute, and her participation with industry in a broad range of industry association and community groups.
Paul Keim, Phd - 2012 Bioscience Researcher of the Year
Dr. Paul Keim is the Cowden Endowed Chair of Microbiology at Northern Arizona University (NAU), the Director of Pathogen Genomics at the Translational Genomics Research Institute (TGen) and research affiliate at Los Alamos National Laboratory (LANL). Dr. Keim’s research focuses on the advancement of forensics and genomics analysis of bacterial pathogens. You may know this globally recognized researcher as ” Doctor Anthrax” (a moniker he gained after 9-11) but there is a lot more to the work Dr. Keim and his team focus on every day.
SynCardia Total Artifical Heart Patient Profile: Charles Okeke | CBS
2011 Bioscience Company of the Year, SynCardia Systems , Inc. is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
MSDx: Company Presentation
MSDx, Inc .provides novel biomarker tools for studying disease processes. The company is focused on commercializing both Research Use Only (RUO) and In VitroDiagnostic (IVD) blood test products that will be used in monitoring neurological, autoimmune, and inflammatory disorders.